Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.69 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.69 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.68 |
| ▸ | PPARG | P37231 | 7/20 | 0.68 |
| ▸ | PPARD | Q03181 | 7/20 | 0.68 |
| ▸ | PPARA | Q07869 | 7/20 | 0.68 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.68 |
| ▸ | TSHR | P16473 | 4/20 | 0.68 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.68 |
| ▸ | TLR2 | O60603 | 2/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | FABP4 | P15090 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.68 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | ESR1 | P03372 | 1/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | PDE4A | P27815 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5820782 | 1.00 | FFAR4 (0.69) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL6156790 | 1.00 | FFAR4 (0.69) | FFAR4FFAR1GPR84PPARGPPARD | |
| Stearic Acid SCHEMBL2345342 | 1.00 | FFAR4 (0.69) | FFAR4FFAR1GPR84PPARGPPARD | |
| Octanoic Acid SCHEMBL20394217 | 1.00 | FFAR4 (0.69) | FFAR4FFAR1GPR84PPARGPPARD | |
| Behenic Acid SCHEMBL20658937 | 1.00 | FFAR4 (0.69) | FFAR4FFAR1GPR84PPARGPPARD | |
| Palmitic Acid SCHEMBL20876307 | 1.00 | FFAR4 (0.69) | FFAR4FFAR1GPR84PPARGPPARD | |
| Myristic Acid SCHEMBL25309729 | 1.00 | FFAR4 (0.69) | FFAR4FFAR1GPR84PPARGPPARD | |
| Decanoic Acid SCHEMBL8937980 | 1.00 | FFAR4 (0.69) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL9580633 | 1.00 | FFAR4 (0.69) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL16418487 | 1.00 | FFAR4 (0.69) | FFAR4FFAR1GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115488988-B | Nonwoven fiber board and preparation method thereof | 江苏神鹭农业发展有限公司 | 2023-07-28 | — | — | CN | claimed |
| US-9365596-B2 | Method for preparing quaternary phosphonium salts | MICROVAST POWER SYSTEMS CO., LTD. (CN) | 2016-06-14 | — | — | US | claimed |
| US-20150166587-A1 | METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS | MICROVAST POWER SYSTEMS CO., LTD. (CN) | 2015-06-18 | — | — | US | claimed |
| CN-121699272-A | High-Wen Kangjun-resistant polyethylene composite plastic and preparation method thereof | 浙江派菲特新材料科技有限公司 | 2026-03-20 | — | — | CN | disclosed |
| CN-112300842-B | Demulsifier for fuel containing quaternary ammonium salt | 雅富顿化学公司 | 2024-04-05 | — | — | CN | disclosed |
| EP-3770234-B1 | DEMULSIFIER FOR QUATERNARY AMMONIUM SALT CONTAINING FUELS | AFTON CHEMICAL CORP (US) | 2023-11-08 | — | — | EP | disclosed |
| CN-115488988-B | Nonwoven fiber board and preparation method thereof | 江苏神鹭农业发展有限公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-109195597-B | Azelaic acid ester for treating insulin resistance | 新前沿实验室有限责任公司 | 2021-08-24 | — | — | CN | disclosed |
| US-11008526-B2 | Demulsifier for quaternary ammonium salt containing fuels | CRODA INC. (US) | 2021-05-18 | — | — | US | disclosed |
| CN-112300842-A | Demulsifier for fuel containing quaternary ammonium salt | 雅富顿化学公司 | 2021-02-02 | — | — | CN | disclosed |
| US-20210024844-A1 | DEMULSIFIER FOR QUATERNARY AMMONIUM SALT CONTAINING FUELS | CRODA INC. (US) | 2021-01-28 | — | — | US | disclosed |
| EP-0291074-B1 | PROCESS FOR PRODUCING QUATERNARY SALTS | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1992-01-29 | — | — | EP | disclosed |
| EP-0227433-B1 | ELECTROLYTE SOLUTION OF QUATERNARY AMMONIUM SALT FOR ELECTROLYTIC CAPACITOR | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1992-01-15 | — | — | EP | disclosed |
| EP-0246825-B1 | QUATERNARY SALT SOLUTION ELECTROLYTE FOR ELECTROLYTIC CAPACITORS | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1991-02-27 | — | — | EP | disclosed |
| US-4892944-A | Process for producing quaternary salts | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1990-01-09 | — | — | US | disclosed |
| EP-0291074-A2 | Process for producing quaternary salts | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1988-11-17 | — | — | EP | disclosed |
| US-4774011-A | Electrolyte for aluminum electrolytic capacitor | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1988-09-27 | — | — | US | disclosed |
| US-4715976-A | QUATERNARY AMMONIUM SALT OF CARBOXYLIC ACID IN APROTIC SOLVENT | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1987-12-29 | — | — | US | disclosed |
| EP-0246825-A2 | Quaternary salt solution electrolyte for electrolytic capacitors | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1987-11-25 | — | — | EP | disclosed |
| EP-0227433-A2 | Electrolyte solution of quaternary ammonium salt for electrolytic capacitor | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1987-07-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150166587-A1 | METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS | PHPT1, PHOSPHO1, PTEN | FFAR4 2341/4885FFAR1 2869/4885GPR84 3736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.